EUVIMEDEUVIMED entdecken
Crossref

CCR2‐Engineered Macrophage Membrane‐Coated Metal‐Polyphenol Nanozyme to Enhance Antioxidation Activity for Inhibiting the Atherosclerotic Progression

Meng Yan, Yuan Zhong, Sheng Ni, Shirong Zhang, Yingying Jiang, Li Zhu, Kun Zhang, Kaiyong Cai, Kai Qu, Chuanwei Li, Wei Wu iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202502151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Meng Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Biorheological Science & Technology of Ministry of Education, State & Local Joint Engineering Laboratory for Vascular Implants, Bi…. Hauptthemen laut MEDLINE: Receptors, CCR2, Macrophages, Atherosclerosis, Polyphenols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fundamental Research Funds for the National Key R&D Project, Natural Science Foundation of Chongqing, Chongqing medical scientific research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a prevalent chronic inflammatory disease characterized by excessive accumulation of reactive oxygen species (ROS) and persistent inflammation. Polyphenolic natural antioxidants possess strong ROS‐scavenging properties. However, the poor targeting ability and rapid metabolism greatly limit their further clinical applications. To this end, a multifunctional biomimetic nanoplatform (CCR2@NPs) is developed by engineering macrophage membranes with the overexpressed C‐C chemokine receptor 2 (CCR2) and subsequently enhances the target delivery to inflammatory lesions of AS via the C‐C motif ligand 2 (CCL2)/CCR2 chemotactic signaling pathway for significantly improving drug bioavailability. In pathological local lesions, CCR2@NPs can effectively scavenge the excessive ROS, alleviate vascular injury, and finally inhibit AS progression. This strategy enables precise, synergistic therapy and offers new insights into the potential treatment approaches for AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR2MacrophagesAtherosclerosisPolyphenolsAntioxidantsAnimalsMiceReactive Oxygen SpeciesRAW 264.7 CellsHumansMaleMice, Inbred C57BL

Stichwörter der Autor:innen

CCR2 genetically engineered macrophageantioxidantatherosclerosismembrane‐coated nanoparticlesmetal‐polyphenols nanozymes

Substanzen

Receptors, CCR2PolyphenolsAntioxidantsReactive Oxygen SpeciesCcr2 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory for Biorheological Science & Technology of Ministry of Education, State & Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing University Thr…
  • Jinfeng Laboratory, Chongqing, 401329, China.

ORCID-Profile: Wei Wu

Förderung

  • Fundamental Research Funds for the National Key R&D Project
  • Natural Science Foundation of Chongqing
  • Chongqing medical scientific research project
  • Joint project of Chongqing Health Commission and Science and Technology Bureau
  • Fundamental Research Funds for Central Universities
  • JinFeng Laboratory of Chongqing
  • Science and Technology Research Program of Chongqing Municipal Education Commission
  • National Defense Foundation Strengthening Program

Zitieren

APA

Yan, M., Zhong, Y., Ni, S., Zhang, S., Jiang, Y., Zhu, L., Zhang, K., Cai, K., Qu, K., Li, C., & Wu, W. (2026). CCR2‐Engineered Macrophage Membrane‐Coated Metal‐Polyphenol Nanozyme to Enhance Antioxidation Activity for Inhibiting the Atherosclerotic Progression. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502151

Vancouver

Yan M, Zhong Y, Ni S, Zhang S, Jiang Y, Zhu L, et al. CCR2‐Engineered Macrophage Membrane‐Coated Metal‐Polyphenol Nanozyme to Enhance Antioxidation Activity for Inhibiting the Atherosclerotic Progression. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502151

BibTeX
@article{Yan2026,
  author = {Yan, Meng and Zhong, Yuan and Ni, Sheng and Zhang, Shirong and Jiang, Yingying and Zhu, Li and Zhang, Kun and Cai, Kaiyong and Qu, Kai and Li, Chuanwei and Wu, Wei},
  title = {CCR2‐Engineered Macrophage Membrane‐Coated Metal‐Polyphenol Nanozyme to Enhance Antioxidation Activity for Inhibiting the Atherosclerotic Progression},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202502151}
}
Kostenlos starten →